Vaccine hesitancy in Europe
15 March 2017
Vaccination is one of the most cost-effective health interventions available, saving millions of people from illness, disability and death each year. Currently, 20 different effective and safe vaccines are in use around Europe, and many promising new or improved ones are being developed. EU Member States spend on average 3% of their health budgets on reduction and protection against a range of serious diseases by immunisation. Certain diseases have already been eradicated by rigorous vaccination campaigns, while others are hoped to be eliminated soon, such as measles and congenital rubella. According to the WHO European Regional Verification Commission for measles and rubella elimination, 24 EU Member States had completely eliminated both diseases by October 2016. New vaccines are being developed against existing diseases such as infections with human papillomavirus.
Despite being one of the greatest public health achievements of the 20th century, vaccination is facing significant growing public concerns regarding safety and legislation. In recent times, an important number of in the population have become distrustful of vaccination for a variety of reasons: the risk of side effects, the safety of vaccine ingredients and the lack of trust in the provider, to name but a few. The EHMA Secretariat attended the conference ‘Vaccine hesitancy in Europe: facts, opinions and the way forward’, organised by DG SANTE on 15 February 2017.
- Certain diseases have already been eradicated by rigorous vaccination campaigns, while others are hoped to be eliminated soon, such as measles and congenital rubella.
- 20 different effective and safe vaccines are in use around Europe, and many promising new or improved ones are being developed.
- Vaccination is facing significant growing public concerns about vaccine safety and legislation.
- To enhance people’s confidence in vaccination and addresses common issues, involvement of multiple stakeholders in decision-making should be encouraged.
What is ‘vaccine hesitancy’?
Vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite availability of vaccination services. According to the Strategic Advisory Group of Experts to the WHO, vaccine hesitancy is a behaviour, influenced by a number of factors including issues of confidence, complacency and convenience. Vaccine-hesitant individuals have different levels of concern about vaccines, including false beliefs, ignorance and lack of advocacy1.
Vaccine-safety related sentiment is particularly negative in the European region, which has seven of the ten least confident countries, with 41% of respondents in France and 36% of respondents in Bosnia & Herzegovina reporting that they disagree that vaccines are safe (compared to a global average of 13%)2.
Vaccine hesitancy determinant categories
- Confidence. Loss of trust in vaccines, public health actors and delivery systems.
- Complacency. Vaccination is not deemed a necessary preventive action.
- Convenience. Availability; affordability; geographical access; ability to understand; and appeal of immunisation services
State of play of vaccination in Europe
Almost all countries have national and/or regional vaccination policies or strategies to prevent different diseases in place. Certain diseases have already been eradicated by rigorous vaccination campaigns, while others are hoped to be eliminated soon, such as measles and congenital rubella3.
In 2014, the Council of the European Union recognised that an evidence-based, cost-effective, safe and efficient immunisation system is an integral part of a well-functioning health system4. The Council also highlighted that in recent years there have been outbreaks of vaccine preventable diseases such as measles, polio and pertussis although they were on the way to being eradicated or eliminated. In addition, Member States have done an estimation of the costs for activities such as targeted initiatives for key risk populations to raise awareness, improve access to vaccination, increase coverage rates (‘costed action plans’) and reported that adequate funding had been allocated for the implementation of vaccination plans5.
Among the plans and project developed in Europe, it should be highlight the European Vaccine Action Plan 2015–2020 (EVAP) 6. EVAP is a regional interpretation of the Global Vaccine Action Plan developed to address the specific needs and challenges related to immunization in the WHO European Region.
The objectives of EVAP, echo the policy priorities of Health 2020, through which the Region is committed to reduce inequities and thus significantly improve the health and well-being of populations, strengthen public health and ensure people-centred health systems that are equitable, sustainable and of high quality (Table 1).
Figure 1. WHO Regional Office for Europe
Public trust deficit
The perception of the European population on vaccination has become one of the main challenges to achieve further progress and innovative solution for disease preventions. A range of global factors are contributing to increased public questioning of vaccines, but the determinants of public trust are complex and not always well understood.
Such public trust deficit is highly variable depending on multiple factors, including understanding perceptions of vaccines and vaccine risks, historical experiences, religious or political affiliations, and socioeconomic status. As ECDC declared, the most common determinant of vaccine hesitancy in Europe is concerns or fears about vaccine safety. This includes many specific beliefs, such as the fear of adjuvants or side effects, but is overall a problem of risk perception. Qualitative studies addressing vaccine safety and risk perception in Europe would bring considerable value and benefits to currently available evidence.
Boosting vaccine confidence
The WHO Centre of Excellence, Vaccine Confidence Project, is currently focused on monitoring public confidence in immunisation programmes by building an information surveillance system for early detection of public concerns around vaccines; by applying a diagnostic tool to data collected to determine the risk level of public concerns in terms of their potential to disrupt vaccine programmes; and, finally, to provide analysis and guidance for early response and engagement with the public to ensure sustained confidence in vaccines and immunisation7.
As the project indicates, the effect of faith on vaccine attitudes is dependent on local context, and that these attitudes are not necessarily driven by religious doctrine in itself, but mediated by political, socio-cultural and other factors8. Thus, understanding vaccine confidence means understanding a range of determinants whose influences often live outside an immunisation or even health programme but affect both confidence in and acceptance of vaccines. These determinants can be grouped into:
- Contextual factors. Influences arising due to historic, sociocultural, environmental, health system/institutional, economic or political factors.
- Individual and group influences. Influences arising from personal perception of the vaccine or influences of the social/peer environment.
- Vaccine/vaccination specific issues. Influences directly related, including: scientific evidence; design of vaccination program; reliability of vaccine supply; costs and role of healthcare professionals.
To enhance people’s confidence in vaccination and addresses common issues, involvement of multiple stakeholders in decision-making should be encouraged by joining public health experts, policy-makers and patients; explaining and clarifying every process related to vaccine industry; and evaluating benefit/risk relations.
EHMA would like to provide you a selection of articles and official documents based at the European and global level as must reads if you wish to learn more. Among the following selection, you could find documents launched by the European Commission, the European Centre for Disease Prevention and Control (ECDC) and the WHO.
- ECDC, Vaccine hesitancy among healthcare workers and their patients in Europe, 2015
- The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey
- ECDC, Vaccine-preventable diseases briefing page
- Council of the European Union, Council conclusions on vaccinations as an effective tool in public health, 2014
- European Commission, Working Document – State of play on implementation of the Council Recommendation of 22 December 2009 on seasonal influenza vaccination, 2014
- WHO Europe, European Vaccine Action Plan 2015-2020, 2015
- Vaccine Confidence Project, Website
- Vaccine Confidence Project, The State of Vaccine Confidence 2016, 2016
We also invite you to read this Rapid literature review on motivating hesitant population groups in Europe to vaccinate, by the ECDC focuses on identifying hesitant population groups and how targeting them.
Watch the full recording of the Conference ‘Vaccination Hesitancy In Europe: Facts, Opinions and The Way Forward’ here and subscribe to the Vaccine Confidence Project newsletter to get the latest news on this topic.
This blog was written by Aurora Mantas
RSV immunisation for infants in Europe: are our health systems ready?
Proposed amendments to the reformed Pharmaceutical Legislation: patient safety and medication shortages
Discover the European Health Management Conference Tracks
What our Members say
I have been active in EHMA since the first years of the '90s and I have seen its evolution from a small association of members interested in sharing knowledge on health management practices to the current status of reference and advisory key player for EU, health systems and organisations, stakeholders associations, industry and universities. EHMA is now a unique knowledge hub, policy advisor, community of practice and network of best in class organisations involved in health policy and management. A place where health managers can build their competences, policy-makers and stakeholder associations envision how to implement and sustain change through health management, industry leaders understand how to engage more effectively with health organisations and systems. The right place to nurture and grow health management capabilities and capacity for every stakeholder of health systems.
Prof. Federico Lega, University of Milan, Italy
Health management has a crucial function in shaping public health and health system challenges. The Medical University of Varna, Bulgaria had success in collaborating with EHMA on EU-funded projects that has resourced us to create new health management competencies for the future workforce. In addition to all classical definitions, health management is a science dealing with individuals, groups, and society at large. It is an art contributing to the beauty of our lives and an interactive communication process at all levels of institutions and human energy. I have also had the pleasure to chair the South Eastern European Special Interest Group which gives members a space to discuss and tools to address how health systems are managed in our regions.
Prof. Todorka Kostadinova, Medical University of Varna, Bulgaria
I enjoy the high level of interaction and engagement in EHMA’s activities, in particular during the annual conference where the panel discussions are rich and well prepared. As a hospital manager and professor of health management, EHMA motivates and inspires me to be creative. You go back home feeling energised from seeing old friends and making new connections, as well as being convinced of serving as EHMA’s ambassador. It’s a strong feeling of interdisciplinary engagement, but it also feels like being part of family-like community.
Prof. Sandra C. Buttigieg, University of Malta, Malta
EHMA is a pre-eminent organisation for everyone working in planning, managing and delivering health services across Europe. As a long standing member of EHMA I have always been impressed by the vibrant community of managers, researchers and academics it has created and by the many opportunities for sharing knowledge and funding opportunities it has brought to its members. Its international scope is impressive and its impact is often felt in management and research across European and national health systems.
Prof. Axel Kaehne, Edge Hill University, UK
Health workforce has become more essential in operating, managing and maintaining health systems lately, particularly in crisis and emergency situations. European healthcare professions and the workforce need to be high on the agenda of managers and decision makers. The Health Services Management Training Centre, Semmelweis University in Hungary is a longstanding EHMA member, because it connects us with collaborators and experts, with whom we can have complex debates, from whom we can learn and at the end find solutions in various challenging fields of healthcare management.
Dr Eszter Kovács, Health Services Management Training Centre, Semmelweis University, Hungary
As a hospital administrator and health management professor, I see on a daily basis that the healthcare challenges require talented and skilled managers to transform it. the EHMA membership has been beneficial to bring healthcare management research and education to the demanding healthcare services world, promoting healthcare management competencies and knowledge creation.
Dr Alexandre Lourenco, APAH - Association of Portuguese Hospital Managers, Portugal
Many healthcare systems in Europe and beyond are facing similar challenges which require innovative and creative solutions. EHMA’s annual conference, webinars, Programme Directors’ group and other activities and resources provide incredible opportunities for networking, connecting and sharing experiences. A distinct feature of EHMA is the diversity of members with representation from many countries, sectors and different communities of practice – academic, policy-makers, practitioners, managers, leaders and students. The annual conference is a highlight in the calendar year, offering a friendly, fun and learningful environment for emerging and established members to engage, collaborate and meet up with old and new friends. I am proud to be a member of the EHMA Board.
Prof. Ann Mahon, University of Manchester, UK
Society evolution, pandemics and ageing modify health needs. So, health policies and services are to change dramatically. EHMA, through webinars, workshops and annual conference provides an excellent insight to a professional changing world, favouring closeness to management innovation and the protagonists of these changes. As a primary care services’ manager, participating in EHMA activities is really worth it and allows to involve oneself in the innovation processes.
Dr Antoni Peris Grao, Consorci Castelldefels Agents de Salut (CASAP), Spain